WallStSmart
ANIK

Anika Therapeutics Inc

NASDAQ: ANIK · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$12.39
-18.81% today

Updated 2026-04-29

Market cap
$165.66M
P/E ratio
P/S ratio
1.47x
EPS (TTM)
$-0.79
Dividend yield
52W range
$8 – $16
Volume
0.1M

Anika Therapeutics Inc (ANIK) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$2.00M$4.49M$3.41M$3.09M$7.85M$10.17M$10.55M$25.16M$39.98M$39.06M$23.80M$40.81M$34.92M$37.01M$13.06M$8.40M$4.41M$-1.79M$5.40M$11.19M
Capital expenditures$1.31M$14.76M$16.25M$3.96M$2.78M$1.40M$1.50M$440890.00$1.55M$9.22M$14.01M$8.98M$4.66M$2.83M$1.63M$5.14M$7.49M$5.43M$7.73M$6.83M
Depreciation
Stock-based comp$1.27B$911.72M$1.39M$958025.00$1.10M$1.19M$1.15M$1.27M$1.61M$2.23M$3.39M$5.81M$11.05M$6.09M$5.39M$11.09M$14.31M$15.24M$13.13M$10.08M
Free cash flow$695371.00$-10.26M$-12.84M$-867527.00$5.07M$8.77M$9.04M$24.72M$38.43M$29.84M$9.79M$31.83M$30.26M$34.18M$11.44M$3.25M$-3.08M$-7.21M$-2.33M$4.36M
Investing cash flow
Financing cash flow
Dividends paid$33.64B$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.26M$642000.00$253000.00
Share repurchases
Debt repayment
Net change in cash$7.58M$8.29M$19.27M$36.82M$10.55M$-6.45M$29.00M$-44.21M$68.42M$-61.97M$-1.50M$-7.93M